Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine F Carpentier

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Bulletin Du Cancer|January 11, 2013
[Brain metastases epidemiology and biology]Emeline Tabouret, Luc Bauchet, Antoine F Carpentier
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant gliomaAntoine F Carpentier, Gregor Auf, Jean-Yves Delattre
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma modelClaire Banissi, François Ghiringhelli, Lin Chen, et al.
Nanomaterials (Basel, Switzerland)|March 29, 2017
Iron Oxide Nanoparticles Coated with a Phosphorothioate Oligonucleotide and a Cationic Peptide: Exploring Four Different Ways of Surface FunctionalizationFrédéric Geinguenaud, Claire Banissi, Antoine F Carpentier, et al.
La Revue Du Praticien|October 23, 2025
[Outlook for the management of glioblastoma]Nicolas Crainic, Renata Ursu, Stefania Cuzzubbo, et al.
Lancet (London, England)|February 1, 2003
Primary brain tumours in adultsAnthony Behin, Khe Hoang-Xuan, Antoine F Carpentier, et al.
Nucleic Acid Therapeutics|July 27, 2011
Adjuvant properties of Cytosine-phosphate-guanosine oligodeoxynucleotide in combination with various polycations in an ovalbumin-vaccine modelSylvie Maubant, Claire Banissi, Samantha Beck, et al.
Vaccine|December 19, 2009
Cytokine content in lymphoid and white adipose tissues after repeated CpG oligodeoxynucleotide administration in trained ratsMounir Chennaoui, Catherine Drogou, Antoine F Carpentier, et al.
Neuroscience Letters|July 13, 2002
CpG-oligodeoxynucleotide rejection of a neuroblastoma in A/J mice does not induce a paraneoplastic diseaseGregor Auf, Lin Chen, Paul Fornès, et al.
Journal of Neuro-Oncology|February 19, 2005
Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseasesLucinda Aguirre-Cruz, Jean-Luc Charuel, Antoine F Carpentier, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Bulletin Du Cancer|January 11, 2013
[Brain metastases epidemiology and biology]Emeline Tabouret, Luc Bauchet, Antoine F Carpentier
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
CpG-oligonucleotides for cancer immunotherapy : review of the literature and potential applications in malignant gliomaAntoine F Carpentier, Gregor Auf, Jean-Yves Delattre
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma modelClaire Banissi, François Ghiringhelli, Lin Chen, et al.
Nanomaterials (Basel, Switzerland)|March 29, 2017
Iron Oxide Nanoparticles Coated with a Phosphorothioate Oligonucleotide and a Cationic Peptide: Exploring Four Different Ways of Surface FunctionalizationFrédéric Geinguenaud, Claire Banissi, Antoine F Carpentier, et al.
La Revue Du Praticien|October 23, 2025
[Outlook for the management of glioblastoma]Nicolas Crainic, Renata Ursu, Stefania Cuzzubbo, et al.
Lancet (London, England)|February 1, 2003
Primary brain tumours in adultsAnthony Behin, Khe Hoang-Xuan, Antoine F Carpentier, et al.
Nucleic Acid Therapeutics|July 27, 2011
Adjuvant properties of Cytosine-phosphate-guanosine oligodeoxynucleotide in combination with various polycations in an ovalbumin-vaccine modelSylvie Maubant, Claire Banissi, Samantha Beck, et al.
Vaccine|December 19, 2009
Cytokine content in lymphoid and white adipose tissues after repeated CpG oligodeoxynucleotide administration in trained ratsMounir Chennaoui, Catherine Drogou, Antoine F Carpentier, et al.
Neuroscience Letters|July 13, 2002
CpG-oligodeoxynucleotide rejection of a neuroblastoma in A/J mice does not induce a paraneoplastic diseaseGregor Auf, Lin Chen, Paul Fornès, et al.
Journal of Neuro-Oncology|February 19, 2005
Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseasesLucinda Aguirre-Cruz, Jean-Luc Charuel, Antoine F Carpentier, et al.
Pageof 8